Patients present with locally advanced disease requiring neoadjuvant treatment.
Despite of advance disease 45% patients had complete pathological response.
Complete pathological response had mean survival of 62.73 months compared to 41.42 months.
Overall mean disease free survival was 58.91 ± 5.57 months.